American International Group Inc. Sells 972 Shares of Baxter International Inc. (NYSE:BAX)

American International Group Inc. lowered its stake in Baxter International Inc. (NYSE:BAX) by 0.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 137,425 shares of the medical instruments supplier’s stock after selling 972 shares during the period. American International Group Inc.’s holdings in Baxter International were worth $5,313,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in BAX. Headinvest LLC acquired a new position in shares of Baxter International during the 3rd quarter worth approximately $25,000. Bruce G. Allen Investments LLC acquired a new stake in shares of Baxter International during the 4th quarter worth approximately $36,000. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Baxter International during the 4th quarter worth approximately $37,000. Hexagon Capital Partners LLC boosted its position in shares of Baxter International by 205.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 953 shares of the medical instruments supplier’s stock worth $37,000 after acquiring an additional 641 shares in the last quarter. Finally, CKW Financial Group acquired a new stake in shares of Baxter International during the 4th quarter worth approximately $43,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

Baxter International Trading Up 0.9 %

NYSE:BAX opened at $34.29 on Friday. The company has a current ratio of 1.48, a quick ratio of 1.01 and a debt-to-equity ratio of 1.35. The stock has a market capitalization of $17.47 billion, a price-to-earnings ratio of 6.59, a PEG ratio of 1.77 and a beta of 0.61. The firm has a fifty day simple moving average of $35.92 and a two-hundred day simple moving average of $38.79. Baxter International Inc. has a 12 month low of $31.01 and a 12 month high of $50.21.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.04. The firm had revenue of $3.59 billion during the quarter, compared to analysts’ expectations of $3.55 billion. Baxter International had a net margin of 17.79% and a return on equity of 18.47%. The business’s revenue was down 1.6% on a year-over-year basis. During the same period last year, the company earned $0.59 earnings per share. Analysts expect that Baxter International Inc. will post 2.91 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Friday, May 31st will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date of this dividend is Friday, May 31st. Baxter International’s payout ratio is currently 22.31%.

Analyst Upgrades and Downgrades

BAX has been the subject of several research reports. The Goldman Sachs Group initiated coverage on shares of Baxter International in a research note on Thursday, May 30th. They issued a “neutral” rating and a $36.00 price objective for the company. Bank of America raised their price target on shares of Baxter International from $42.00 to $45.00 and gave the company a “neutral” rating in a research note on Tuesday, March 5th. TD Cowen downgraded shares of Baxter International from a “buy” rating to a “hold” rating and set a $40.00 price target for the company. in a research note on Friday, May 10th. Finally, Citigroup dropped their price target on shares of Baxter International from $44.00 to $38.00 and set a “neutral” rating for the company in a research note on Wednesday, May 22nd. Nine research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Baxter International currently has a consensus rating of “Hold” and an average price target of $44.42.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.